Literature DB >> 3356957

Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long-Evans rat: effect of adrenalectomy and dexamethasone.

D J Eckland1, K Todd, S L Lightman.   

Abstract

Immunoreactive vasopressin and oxytocin were measured in the hypothalamo-hypophysial portal blood of both Long-Evans and homozygous Brattleboro rats. Adrenalectomy caused an increase in vasopressin immunoreactivity in portal blood in the Long-Evans strain, whilst administration of dexamethasone to these adrenalectomized animals resulted in a reduction in portal vasopressin immunoreactivity to levels below those seen in sham-operated animals. This vasopressin immunoreactivity co-eluted with synthetic vasopressin on high-pressure liquid chromatography (HPLC), and diluted in parallel in radio-immunoassay. In Brattleboro rats, however, although vasopressin-like immunoreactivity was detected, the portal concentration did not vary with the adrenal status of the animal, nor did it show the characteristics of standard vasopressin on HPLC or in immunoassay. Oxytocin was present in the portal blood of both Long-Evans and Brattleboro rats at similar very high concentrations, but did not vary in response to adrenalectomy. These results are consistent with a role for vasopressin, but not oxytocin, in the hypothalamic response to adrenalectomy and glucocorticoid feedback. Neither vasopressin immunoreactivity nor oxytocin appear to subserve this role in the homozygous Brattleboro rat.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356957     DOI: 10.1677/joe.0.1170027

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress.

Authors:  S L Lightman; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  Vasopressin RNA in the neural lobe of the pituitary: dramatic accumulation in response to salt loading.

Authors:  D Murphy; A Levy; S Lightman; D Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.

Authors:  S L Lightman; W S Young
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

4.  Attenuated stress response to acute restraint and forced swimming stress in arginine vasopressin 1b receptor subtype (Avpr1b) receptor knockout mice and wild-type mice treated with a novel Avpr1b receptor antagonist.

Authors:  J A Roper; M Craighead; A-M O'Carroll; S J Lolait
Journal:  J Neuroendocrinol       Date:  2010-11       Impact factor: 3.627

5.  Simultaneous detection of neuropeptides and messenger RNA in the magnocellular hypothalamo-neurohypophysial system by a combination of non-radioactive in situ hybridization histochemistry and immunohistochemistry.

Authors:  P J Larsen; J D Mikkelsen
Journal:  Histochemistry       Date:  1994-12

6.  The suprachiasmatic nucleus of the mink (Mustela vison): apparent absence of vasopressin-immunoreactive neurons.

Authors:  P J Larsen; J D Mikkelsen
Journal:  Cell Tissue Res       Date:  1993-08       Impact factor: 5.249

7.  Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis.

Authors:  H S Chowdrey; P J Larsen; M S Harbuz; D S Jessop; G Aguilera; D J Eckland; S L Lightman
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  Inhibitory effect of dexamethasone on the oxytocin response to insulin-induced hypoglycemia in normal men.

Authors:  P Chiodera; R Volpi; A Caiazza; C Davoli; C Marchesi; C Papadia; L Capretti; R Bocchi; V Coiro
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.